COAG - CIK 0002114044
As of 2026-06-10, Hemab Therapeutics Holdings, Inc. (COAG) has a market capitalization of $1.17 B, making it the #2524 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-06-10 | $1.17 B |
| 2026-05-29 | $1.27 B |
| 2026-05-28 | $1.26 B |
| 2026-05-26 | $1.19 B |
| 2026-05-25 | $1.14 B |
| 2026-05-24 | $1.14 B |
| 2026-05-22 | $1.14 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
As of 2026-06-10, Hemab Therapeutics Holdings, Inc. (COAG) has a market capitalization of $1.17 B, making it the #2524 most valuable US-listed company.
Hemab Therapeutics Holdings, Inc. is the #2524 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.